SCARA5 and esophageal squamous cell carcinoma: Meanwhile, to further determine the expression of SCARA5 in ESCC tissues, we collected pathological sections of 20 patients to perform IHC analysis (Table 1), and the results exhibited that the intensity of SCARA5 immunostaining in the ESCC tissues was significantly decline compared with that in the matched non-cancerous tissues (Fig. 1F).